Hikma Pharmaceuticals Plc Director/PDMR Shareholding (6672Q)
June 22 2020 - 6:22AM
UK Regulatory
TIDMHIK
RNS Number : 6672Q
Hikma Pharmaceuticals Plc
22 June 2020
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Extension of existing pledge by Darhold Limited
transaction of 1,500,000 Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in support of a
loan, in favour of J.P. Morgan (Suisse) SA.
Darhold Limited is defined as a Person Closely
Associated with the Executive Chairman, who
is a director and shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 1,500,000
d) Aggregated information Aggregated volume: 1,500,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Extension of existing pledge by Darhold Limited
transaction of 1,500,000 Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in support of a
loan, in favour of J.P. Morgan (Suisse) SA.
Darhold Limited is defined as a Person Closely
Associated with the Executive Vice Chairman,
who is a director and shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 1,500,000
d) Aggregated information Aggregated volume: 1,500,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Mohammed 'Ali' Al-Husry
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mohammed 'Ali' Al-Husry
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Extension of existing pledge by Darhold Limited
transaction of 1,500,000 Ordinary Shares of 10 pence each
in Hikma Pharmaceuticals PLC in support of a
loan, in favour of J.P. Morgan (Suisse) SA.
Darhold Limited is defined as a Person Closely
Associated with the Non-Executive Director,
who is a director and shareholder of Darhold.
c) Price(s) and Price(s): GBP0.00p
volume(s) Volume(s): 1,500,000
d) Aggregated information Aggregated volume: 1,500,000
Price: GBP0.00p
e) Date of the transaction 22 June 2020
f) Place of the Amman
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBGGDLGDDDGGD
(END) Dow Jones Newswires
June 22, 2020 06:22 ET (10:22 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024